# OnCo record primary-testicular-lymphoma (cancer). Data CC BY-NC 4.0, attribute "Data from OnCo (onco.cc)". Whole corpus: https://onco.cc/api/v1/onco.nt
@prefix schema: <https://schema.org/> .
@prefix onco: <https://onco.cc/ns#> .
@prefix xsd: <http://www.w3.org/2001/XMLSchema#> .

<https://onco.cc/cancers/primary-testicular-lymphoma/>
  a schema:MedicalCondition ;
  onco:kind "cancer" ;
  schema:identifier "primary-testicular-lymphoma" ;
  schema:name "Primary large B-cell lymphoma of the testis"@en ;
  schema:alternateName "Primary testicular lymphoma"@en, "PTL"@en, "Primary testicular diffuse large B-cell lymphoma"@en, "Testicular lymphoma"@en, "Primary diffuse large B-cell lymphoma of the testis"@en, "Primary large B-cell lymphoma of immune-privileged sites"@en ;
  schema:description "A large B-cell lymphoma that starts in a testicle rather than in a lymph node, usually in a man over 60, and shows itself as a painless swelling. It is the commonest cancer of the testicle in older men, and it behaves as one disease with lymphoma of the brain and of the eye, which is why treatment deliberately protects both."@en ;
  schema:url <https://onco.cc/cancers/primary-testicular-lymphoma/> ;
  schema:dateModified "2026-09-29"^^xsd:date ;
  schema:sameAs <https://en.wikipedia.org/wiki/Primary_testicular_diffuse_large_B-cell_lymphoma> ;
  schema:citation <https://doi.org/10.1038/s41375-022-01620-2>, <https://doi.org/10.1182/blood.2022015851>, <https://doi.org/10.1200/JCO.2010.31.4187>, <https://doi.org/10.1200/JCO.2009.22.5896>, <https://www.cancer.gov/types/lymphoma/hp/adult-nhl-treatment-pdq> ;
  onco:tag "heme", "lymphoma", "subtype-page" ;
  onco:related <https://onco.cc/cancers/primary-cns-lymphoma/>, <https://onco.cc/cancers/dlbcl/>, <https://onco.cc/cancers/testicular/>, <https://onco.cc/cancers/non-hodgkin-lymphoma/>, <https://onco.cc/cancers/intravascular-large-b-cell-lymphoma/> ;
  onco:technologies <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/technologies/fdg-pet/>, <https://onco.cc/technologies/imrt-igrt/> ;
  onco:drugs <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/methotrexate/> ;
  onco:terms <https://onco.cc/terms/lymphoma-nodal-versus-extranodal/>, <https://onco.cc/terms/lymphoma-classification-2022/>, <https://onco.cc/terms/lymphoma-tx-cns-prophylaxis/>, <https://onco.cc/terms/lymphoma-tx-fertility-preservation/>, <https://onco.cc/terms/myd88-l265p/>, <https://onco.cc/terms/ipi-score/> ;
  onco:standardOfCare <https://onco.cc/technologies/fdg-pet/>, <https://onco.cc/terms/lymphoma-tx-fertility-preservation/>, <https://onco.cc/terms/lugano-classification/>, <https://onco.cc/technologies/histopathology-ihc/>, <https://onco.cc/drugs/rituximab/>, <https://onco.cc/drugs/cyclophosphamide/>, <https://onco.cc/drugs/doxorubicin/>, <https://onco.cc/drugs/vincristine/>, <https://onco.cc/drugs/prednisone/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/terms/intrathecal-therapy/>, <https://onco.cc/technologies/imrt-igrt/>, <https://onco.cc/terms/lymphoma-tx-cns-prophylaxis/>, <https://onco.cc/cancers/primary-cns-lymphoma/>, <https://onco.cc/drugs/methotrexate/>, <https://onco.cc/technologies/autologous-stem-cell-transplant/>, <https://onco.cc/terms/lymphoma-tx-transplant-role/> .